Development of a selective PAD2 inhibitor for the treatment of inflammatory disease​

By admin , 7 October, 2026
ID
M202610070114
Pathway
Entrepreneurship, Biomedical Design, and Innovation
Goals
Identify lead indication for the technology; understand how the technology would be used in the healthcare ecosystem, including how it would displace existing technologies; identify the top 3 customer types that would use this technology
Mentor
Paul Thompson (Contact Nate Hafer)
Mentor E-mail
nathaniel.hafer@umassmed.edu
Department
BMB
Availability
Yes
Number Spots
up to 5